|
McDep
Stock Idea by email SEC
Investigation of Kinder Morgan May Be Catalyst for Revaluation After
the market close on May 5, sell recommended Kinder Morgan (KMI, KMP, KMR)
announced that the Securities and Exchange Commission was investigating the
"high greed" partnership's accounting.
That
could be the catalyst for the revaluation of Kinder Morgan that seems likely
eventually by our analysis. High
McDep Ratio, high ratio of debt stocks like Kinder Morgan have low tolerance for
doubt. There is little upside left
after heavy promotion and the downside is limited only by a stock price of zero. The
investigation of Kinder Morgan gives new promise that the SEC may be recognizing
a fertile target for limited regulatory resources.
Until now the SEC seems to have looked the other way with regards to
partnerships that have the "high greed" compensation formula.
About a month ago the commission apparently gave the partnerships a pass
on the independent audit committee requirement of Sarbanes-Oxley reform.
That looks to us like the SEC is blessing Ponzi income schemes and Insull
debt pyramids covered up with Enron accounting.
If there is any portion of the energy industry after the failed power
sector that needs SEC attention and the application of the principles of new
legislation, it is the offending partnerships in our opinion.
Picking
up on the independent audit committee, we see a need for more realistic
accounting for the general partner's compensation.
Just as convertible securities are accounted as dilutive when stock price
is above conversion price, the GP compensation should be accounted as dilutive
when the GP takes an increasing share of value.
A large equity interest for a GP that takes a large share implies
writedowns of value for the limited partners.
A truly independent audit would impose such a charge.
If the SEC presses in that direction, we ought to see billion dollar
earnings restatements. What
we see in the accounting for the Tejas acquisition, the transaction in question,
is that the limited partners are charged for the full cost of the acquisition
and only receive about half the benefits. The
GP is charged nothing and gets the other half of benefits.
The balance sheet is out of whack with the cash flow and income
statements. Questions
about accounting are often the first public indications that fraud is about to
be uncovered. We hope the SEC will
at least require the presentation of more realistic financial statements for
continued access to the public markets by high greed partnerships. Kurt
H. Wulff, CFA
|